Alpha 2.0
Login Register
» Authors » Lukasz Tanajewski

Lukasz Tanajewski

Explore the profile of Lukasz Tanajewski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 143
Followers 0
Related Specialties
General Medicine
Pharmacology
Health Services
Top 10 Co-Authors
Georgios Gkountouras
Rachel A Elliott
Vladislav Berdunov
Antony Chuter
Justin Waring
Asam Latif
Anthony J Avery
Matthew Franklin
Simon Conroy
Nick Barber
Published In
BMJ Qual Saf
PLoS One
Trials
Pilot Feasibility Stud
Neuroscience
Affiliations
Soon will be listed here.
Recent Articles
1.
Cognitive load reduces the reinforcement of ventral striatum by anterior insula in taste processing: An fMRI study on self-control
Skalbania J, Tanajewski L, Furtak M, Rynkiewicz A, Wypych M
Neuroscience . 2025 Feb; 569:123-132. PMID: 39909338
Recent studies have shown that cognitive overload disrupted the affective processing of taste attributes in food-related tasks, which is difficult to explain using dual-system theories with their reflective and impulsive...
2.
Pre-choice midbrain fluctuations affect self-control in food choice: A functional magnetic resonance imaging (fMRI) study
Skalbania J, Tanajewski L, Furtak M, Hare T, Wypych M
Cogn Affect Behav Neurosci . 2024 Oct; 25(2):387-401. PMID: 39379768
Recent studies have shown that spontaneous pre-stimulus fluctuations in brain activity affect higher-order cognitive processes, including risky decision-making, cognitive flexibility, and aesthetic judgments. However, there is currently no direct evidence...
3.
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT
Langton Hewer S, Smyth A, Brown M, Jones A, Hickey H, Kenna D, et al.
Health Technol Assess . 2021 Nov; 25(65):1-128. PMID: 34806975
Background: People with cystic fibrosis are susceptible to pulmonary infection with . This may become chronic and lead to increased mortality and morbidity. If treatment is commenced promptly, infection may...
4.
'New Medicine Service': supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial
Elliott R, Boyd M, Tanajewski L, Barber N, Gkountouras G, Avery A, et al.
BMJ Qual Saf . 2019 Nov; 29(4):286-295. PMID: 31732700
Objective: To examine the effectiveness and cost-effectiveness of the community pharmacy New Medicine Service (NMS) at 26 weeks. Methods: Pragmatic patient-level parallel randomised controlled trial in 46 English community pharmacies....
5.
Withdrawal of antihypertensive therapy in people with dementia: feasibility study
der Wardt V, K Burton J, Conroy S, Welsh T, Logan P, Taggar J, et al.
Pilot Feasibility Stud . 2018 Jan; 4:29. PMID: 29340166
Background: This study explored the feasibility of a randomised controlled withdrawal trial of antihypertensive medication in normotensive people with dementia. Feasibility aspects included response, recruitment, exclusion and drop-out rates, suitability...
6.
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice
Elliott R, Tanajewski L, Gkountouras G, Avery A, Barber N, Mehta R, et al.
Pharmacoeconomics . 2017 Aug; 35(12):1237-1255. PMID: 28776320
Background: The English community pharmacy New Medicine Service (NMS) significantly increases patient adherence to medicines, compared with normal practice. We examined the cost effectiveness of NMS compared with normal practice...
7.
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
Tanajewski L, Harris R, Harman D, Aithal G, Card T, Gkountouras G, et al.
BMJ Open . 2017 Jul; 7(6):e015659. PMID: 28679676
Objectives: To assess the long-term cost-effectiveness of a risk stratification pathway, compared with standard care, for detecting non-alcoholic fatty liver disease (NAFLD) in primary care. Setting: Primary care general practices...
8.
Economic Evaluation of a General Hospital Unit for Older People with Delirium and Dementia (TEAM Randomised Controlled Trial)
Tanajewski L, Franklin M, Gkountouras G, Berdunov V, Harwood R, Goldberg S, et al.
PLoS One . 2015 Dec; 10(12):e0140662. PMID: 26684872
Background: One in three hospital acute medical admissions is of an older person with cognitive impairment. Their outcomes are poor and the quality of their care in hospital has been...
9.
Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service
Elliott R, Boyd M, Salema N, Davies J, Barber N, Mehta R, et al.
BMJ Qual Saf . 2015 Dec; 25(10):747-58. PMID: 26647412
Objective: To examine the effectiveness of the New Medicine Service (NMS), a national community pharmacy service to support medicines-taking in people starting a new medicine for a long-term condition, compared...
10.
Cost-Effectiveness of a Specialist Geriatric Medical Intervention for Frail Older People Discharged from Acute Medical Units: Economic Evaluation in a Two-Centre Randomised Controlled Trial (AMIGOS)
Tanajewski L, Franklin M, Gkountouras G, Berdunov V, Edmans J, Conroy S, et al.
PLoS One . 2015 May; 10(5):e0121340. PMID: 25942421
Background: Poor outcomes and high resource-use are observed for frail older people discharged from acute medical units. A specialist geriatric medical intervention, to facilitate Comprehensive Geriatric Assessment, was developed to...